Crossmark

Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stages IA to IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic Upstaging

Crossref DOI link: https://doi.org/10.1245/s10434-025-18337-y

Published Online: 2025-09-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mott, Nicole M. https://orcid.org/0000-0003-4834-3400
Meguid, Robert A.

Randhawa, Simran K.

David, Elizabeth A.

Mitchell, John D.

Stuart, Christina M.
License Information

Text and Data Mining valid from 2025-09-20

Version of Record valid from 2025-09-20
More Information

Article History

Received: 21 July 2025

Accepted: 25 August 2025

First Online: 20 September 2025

Disclosure

: Nicole M. Mott is supported by the VA Office of Academic Affiliations through the VA/National Clinician Scholars Program and Michigan Medicine at the University of Michigan. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. Robert A. Meguid reports consulting for Medtronic outside the submitted work. John D. Mitchell reports consulting for Intuitive outside the submitted work. Elizabeth A. David declares advisory board for Astra Zeneca. The remaining authors have no conflicts of interest.

Document is current

Any future updates will be listed below